Status:

UNKNOWN

Study to Compare Standard Perimetry With the New Scotoma-Oriented Perimetry (SCOPE) Using a New Fast German Adaptive Threshold Estimation (GATE) in Glaucoma Patients

Lead Sponsor:

University Hospital Tuebingen

Collaborating Sponsors:

Alcon Research

Conditions:

Primary Open Angle Glaucoma (POAG)

Eligibility:

All Genders

18+ years

Brief Summary

The purpose of this study is to compare the two psychophysical perimetric techniques regarding progression of the visual field.

Eligibility Criteria

Inclusion

  • primary open angle glaucoma (POAG)
  • spherical ametropia max. ± 8 dpt
  • cylindrical ametropia max. ± 3 dpt
  • distant visual acuity \> 10/20
  • pupil diameter \> 3 mm

Exclusion

  • diabetic retinopathy
  • asthma
  • history of epilepsy or significant psychiatric disease
  • medications known to effect visual field sensitivity
  • infections (e.g., keratitis, conjunctivitis, uveitis)
  • severe dry eyes
  • miotic drug
  • squint
  • nystagmus
  • albinism
  • any ocular pathology, in either eye, that may interfere with the ability to obtain visual fields
  • keratoconus
  • intraocular surgery (except for uncomplicated cataract surgery) performed \< 3 month prior to screening
  • history or signs of any visual pathway affection other than glaucoma
  • history or presence of macular disease and/or macular edema, ocular trauma, medications known to affect visual field sensitivity

Key Trial Info

Start Date :

April 1 2010

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2016

Estimated Enrollment :

12 Patients enrolled

Trial Details

Trial ID

NCT00902109

Start Date

April 1 2010

End Date

December 1 2016

Last Update

February 2 2016

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Institute for Ophthalmic Research

Tübingen, Germany, 72076